PCM
CO

Prelude Capital Management’s Global Cord Blood Corporation CO Stock Holding History

Prelude Capital Management’s Portfolio CO Stock Details CO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-9,000
Closed -$50K – 2296
2014
Q2 		$50K Buy
+9,000
New +$40.4K 0.01% 1359

Other funds holding CO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CCM
Cortex Capital Management Fort Worth, Texas $86.4M AUM 1.54% 1-Year Est. Return
MCM
McKinley Capital Management Anchorage, Alaska $571M AUM 36.44% 1-Year Est. Return
EMR
Errol M. Rudman $148M AUM 19.65% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
MYAM
Meiji Yasuda Asset Management Tokyo, Japan $2B AUM 22.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Prelude Capital Management's CO Position: Q3 2014 in Review

Prelude Capital Management sold out of Global Cord Blood Corporation (CO) in Q3 2014, closing a stake of 9,000 shares — an estimated $50K sold.

Prelude Capital Management first reported a position in CO in Q2 2014 and held it in 1 quarter. The position peaked at $50K in Q2 2014. 29 funds tracked by Wall St. Rank hold CO as of Q3 2014.

  • Prelude Capital Management reported no remaining Global Cord Blood Corporation position as of Q3 2014 after selling out during the quarter.
  • Prelude Capital Management sold 9,000 Global Cord Blood Corporation shares in Q3 2014, an estimated $50K.
  • Prelude Capital Management first reported a position in Global Cord Blood Corporation in Q2 2014 and held it in 1 quarter.
  • Prelude Capital Management's Global Cord Blood Corporation position peaked at $50K in Q2 2014.
  • 29 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q3 2014.

Based on Prelude Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.